Zuehlke R L, Lillis P J, Tice A
Int J Dermatol. 1981 Jan-Feb;20(1):57-61. doi: 10.1111/j.1365-4362.1981.tb05295.x.
A retrospective study of 26 quinacrine-treated lupus erythematosus patients failed to show evidence of drug-induced ocular changes. Although quinacrine commonly produces minor side effects, such as yellow discoloration of the skin, and may rarely produce very serious side effects, such as aplastic anemia, it appears to produce much less oculotoxicity than does chloroquine.
一项对26例接受奎纳克林治疗的红斑狼疮患者的回顾性研究未能显示出药物引起眼部变化的证据。尽管奎纳克林通常会产生轻微的副作用,如皮肤发黄,并且可能很少产生非常严重的副作用,如再生障碍性贫血,但它似乎比氯喹产生的眼毒性要小得多。